US Edition‘Sponge-on-a-string’ cancer test introduced in pharmacies
ENGLAND, JUL 9 – The pilot targets 1,500 people with frequent heartburn to detect Barrett's oesophagus early, improving survival by enabling treatment before oesophageal cancer develops.
- NHS England announced that about 1,500 patients will be offered a sponge on a string test in high-street pharmacies in a two-year pilot starting early next year.
- Oesophageal cancer is often diagnosed late, with nearly 10,000 UK cases annually; 80% are late-stage, and only 20% survive beyond a year.
- Patients swallow a capsule on a string that expands into a sponge to collect oesophageal cells for analysis, enabling early cancer detection.
- During the pilot, pharmacists will identify unscreened patients, reducing invasive endoscopies and freeing hospital resources for higher-risk cases.
- Should the two-year NHS England pilot prove successful, it may expand to other regions beyond London and the East Midlands within the next two years, potentially transforming early cancer detection nationwide.
Insights by Ground AI
Does this summary seem wrong?
15 Articles
15 Articles
All
Left
4
Center
4
Right
3
The IndependentReposted by 
The Independent (US)
The Independent (US)New ‘sponge’ cancer test to be trialled in high-street pharmacies
NHS England is piloting a new way of preventing oesophageal cancer
·London, United Kingdom
Read Full Article
Coverage Details
Total News Sources15
Leaning Left4Leaning Right3Center4Last UpdatedBias Distribution36% Left, 36% Center
Bias Distribution
- 36% of the sources lean Left, 36% of the sources are Center
36% Center
L 36%
C 36%
R 27%
Factuality
To view factuality data please Upgrade to Premium
